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a b s t r a c t
The high mobility group box 1 (HMGB1) protein is an endogenous damage-associated molecular pattern
(DAMP) molecule involved in the pathogenesis of various infectious agents. Based on meta-analysis of all
publicly available microarray datasets, HMGB1 has recently been proposed as the most signiﬁcant
immune modulator during the porcine response to porcine reproductive and respiratory syndrome virus
(PRRSV) infection. However, the function of HMGB1 in PRRSV pathogenesis is unclear. In this study, we
found that PRRSV infection triggers the translocation of HMGB1 from the nucleus to the extracellular
milieu in MARC-145 cells and porcine alveolar macrophages. Although HMGB1 has no effect on PRRSV
replication, HMGB1 promotes PRRSV-induced NF-κB activation and subsequent expression of inﬂam-
matory cytokines through receptors RAGE, TLR2 and TLR4. Our ﬁndings show that HMGB1 release,
triggered by PRRSV infection, enhances the efﬁciency of virus-induced inﬂammatory responses, thereby
providing new insights into the pathogenesis of PRRSV infection.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Porcine reproductive and respiratory syndrome (PRRS) is an
economically important infectious disease characterized by severe
reproductive failure in sows, and respiratory distress in piglets and
growing pigs (Lunney et al., 2010; Meng, 2012). The causative
agent, PRRS virus (PRRSV), is a single-stranded positive-sense RNA
virus classiﬁed within the Arteriviridae family (Nelsen et al., 1999;
Snijder et al., 2013). Since its emergence in the late 1980s, PRRS
has been a threat to the global swine industry (Neumann et al.,
2005). Infection with PRRSV causes high fever, severe interstitial
pneumonia and mild lymphocytic encephalitis (Guo et al., 2013;
Liu et al., 2010), suggesting that the inﬂammatory response plays
an important role during infection and pathogenesis. Furthermore,
a large number of studies have reported that PRRSV infection
activates the inﬂammation-related transcription factor NF-κB, and
induces production of pro-inﬂammatory cytokines (IL-6, IL-8 and
TNF-α) (Lee and Kleiboeker, 2005; Luo et al., 2011a; Mateu and
Diaz, 2008; Yoo et al., 2010). However, the underlying mechanisms
of these responses have yet to be elucidated. More recently,
Badaoui et al. (2013) used a new meta-analysis approach to
assess the immune response in pigs to PRRSV infection. This
meta-analysis involved the collection of all publicly available
microarray datasets (six datasets comprising 31,353 probes in
278 chips). They identiﬁed that the most signiﬁcant immune
modulator during the porcine response to PRRSV infection was
high mobility group box 1 (HMGB1). Thus, they proposed that
HMGB1 might be a possible target of PRRSV in the manipulation
of the host immune response.
HMGB1, formerly known as HMG-1 or amphoterin, is a chro-
matin protein ubiquitously expressed by cells. It is highly con-
served and participates in the regulation of chromatin structure; it
is also involved in various aspects of DNA replication, transcription
and repair (Huang et al., 2010; Lotze and Tracey, 2005). HMGB1
can be either passively released from necrotic or damaged cells, or
can be secreted by activated innate immune cells (Mazarati et al.,
2011; Wang et al., 1999). In addition to its nuclear role, HMGB1 is
also a damage-associated molecular pattern (DAMP) molecule that
plays a role during endotoxin shock, vascular injury, lethal sys-
temic and local pulmonary inﬂammation (Bianchi, 2007; Bianchi
and Manfredi, 2007; Higgins et al., 2013; Hirata et al., 2013; Inoue
et al., 2013; Lotze and Tracey, 2005; Tang et al., 2010). Extracellular
HMGB1 acts on several immune cells to trigger inﬂammatory
responses. Known receptors for HMGB1 include toll-like receptor
(TLR) 2, TLR4, TLR9, and the receptor for advanced glycation end
products (RAGE) (Park et al., 2006; Tian et al., 2007). HMGB1-
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mediated TLR2, TLR4, TLR9 and RAGE signaling pathways are
involved in the activation of NF-κB, which contributes to the
production of pro-inﬂammatory molecules by macrophages
(Chen et al., 2012; He et al., 2012; Ivanov et al., 2007; Palumbo
et al., 2007; Park et al., 2004; Tadie et al., 2012).
Considering that HMGB1 is associated with a variety of inﬂam-
matory diseases and PRRSV infection induces severe interstitial
pneumonia, the present study was designed to determine any
relationship between HMGB1 and PRRSV-induced inﬂammatory
cytokines.
Results
PRRSV infection triggers HMGB1 release from MARC-145 cells
and PAMs
To determine whether PRRSV infection triggers the release of
HMGB1 from infected cells, MARC-145 cells were either mock-
infected or infected with PRRSV WUH3. At 30 h post-infection
(hpi), cells were examined using immunoﬂuorescence. A large
amount of nuclear-to-cytoplasmic translocation of HMGB1 was
observed in PRRSV-infected cells (Fig. 1A), while HMGB1 was
infrequently seen in the cytoplasm of mock-infected cells. To
further explore whether PRRSV infection could induce the release
of HMGB1 from the intracellular cytoplasm to extracellular, ELISAs
were conducted to detect the secretion of HMGB1 in cell culture
supernatants. As shown in Fig.1B, the amount of HMGB1 in
supernatants of PRRSV-infected cell cultures is increased com-
pared with that for mock-infected cells at 24 hpi. This increase was
greater than 2-fold at 36 and 48 hpi. When MARC-145 cells were
infected with PRRSV at different multiplicity of infections (MOI)s
(0.001, 0.01, 0.1 and 1), we observed greater levels of HMGB1
secretion at higher MOIs (Fig. 1C), suggesting that HMGB1 release
induced by PRRSV was in a dose-dependent manner. Furthermore,
the release of HMGB1 by PRRSV was likely replication-dependent
because UV-irradiated PRRSV did not signiﬁcantly induce HMGB1
release.
As showed that MARC-145 cells release HMGB1 upon PRRSV
infection, we investigated whether similar HMGB1 translocation
takes place during PRRSV infection in PAMs, the target cells of
PRRSV infection in vivo. As expected, HMGB1 was observed in the
cytoplasm (Fig. 1D) and increasing amount of HMGB1 could be
detected in the supernatant with the progression of infection
(Fig. 1E) in PRRSV-infected PAMs. Also, PRRSV induced HMGB1
release in a dose-dependent manner in PAMs (Fig. 1F). Collectively,
these results unequivocally conﬁrmed that PRRSV infection trig-
gers the release of HMGB1 from the nuclei to extracellular
environment in both MARC-145 cells and PAMs.
HMGB1 does not signiﬁcantly affect PRRSV proliferation
Previous studies suggested that HMGB1 is involved in the
replication of many viruses, such as Hepatitis C virus, inﬂuenza
virus, and HIV (Jung et al., 2011; Moisy et al., 2012; Nowak et al.,
2006). To investigate whether HMGB1 affects PRRSV replication,
three different approaches were performed. Firstly, HMGB1 was
knocked down by siRNA. The designed HMGB1-speciﬁc siRNA
could signiﬁcantly reduce the endogenous expression of HMGB1
in MARC-145 cells (Fig. 2A) and had no detectable cellular toxicity
at the doses tested (data not shown). And then, MARC-145 cells
were transfected with HMGB1-speciﬁc siRNAs (50 nM) or negative
control (NC) (50 nM) prior to PRRSV infection (MOI¼0.1). The
infected cells were collected at 12, 24, 36 and 48 hpi for plaque
assay to determine virus titer. As shown in Fig. 2B, siRNA-mediated
HMGB1 knockdown has no signiﬁcant inﬂuence on PRRSV
replication. In accord with the plaque assay results, expression of
PRRSV Nsp2 was not signiﬁcantly altered in cells transfected with
either HMGB1-speciﬁc siRNAs or control siRNAs (Fig. 2C).
To further conﬁrm the conclusion from siRNA-mediated knock-
down assay, we also used the anti-HMGB1 neutralizing antibody
and puriﬁed HMGB1 protein to evaluate the role of HMGB1 on
PRRSV replication. MARC-145 cells were pretreated with an anti-
HMGB1 neutralizing antibody or recombinant HMGB1 protein at
the indicated concentrations for 18 h prior to PRRSV infection. The
infected cells were cultured in the presence of anti-HMGB1
blocking antibody or HMGB1 protein and collected at different
time points for plaque assay and Western blot analysis. The results
showed that anti-HMGB1 neutralizing antibody did not affect
PRRSV replication (Fig. 2D) and PRRSV Nsp2 expression (Fig. 2E).
Also, puriﬁed HMGB1 protein had no detectable effect on PRRSV
replication (Fig. 2F) and PRRSV Nsp2 expression (Fig. 2G). More-
over, there were no signiﬁcant changes in PRRSV replication at any
time point for the isotype control IgG and control GFP groups.
Taken together, all results from three different assays demon-
strated that HMGB1 might have no effect on PRRSV replication in
MARC-145 cells.
HMGB1 is involved in PRRSV-induced NF-κB activation
and the inﬂammatory response
As a powerful DAMP, HMGB1 has pro-inﬂammatory and
immunomodulatory action (Bianchi and Manfredi, 2007; Scafﬁdi
et al., 2002), and previous studies have showed that PRRSV
infection activates NF-κB pathway (Fu et al., 2012; Lee and
Kleiboeker, 2005; Luo et al., 2011a). To examine whether HMGB1
participates in PRRSV-induced NF-κB activation, MARC-145 cells
were co-transfected with HMGB1-speciﬁc siRNAs, pNF-κB-Luc and
pRL-TK prior to infection with PRRSV. Knockdown of HMGB1
inhibited PRRSV-induced NF-κB transcriptional activity compared
with that for the negative controls (Fig. 3A). Since NF-κB activation
requires NF-κB subunit p65 phosphorylation (Hayden and Ghosh,
2004), we further examined the phosphorylation level of p65
subunit. As expected, HMGB1-speciﬁc siRNA signiﬁcantly inhibited
PRRSV-induced p65 phosphorylation, while total p65 level
remained unchanged (Fig. 3B).
To further validate the effects of HMGB1 on PRRSV-induced NF-
κB activation, pNF-κB-Luc and pRL-TK were co-transfected into
MARC-145 cells before infection with PRRSV. Infected cells were
treated with puriﬁed HMGB1 protein and collected at 36 hpi.
Luciferase assay results showed that treatment with the puriﬁed
HMGB1 protein enhanced PRRSV-induced NF-κB promoter activa-
tion (Fig. 3C) and p65 phosphorylation (Fig. 3D) to some degree.
However no inﬂuence could be observed in cells treated with the
control GFP protein.
NF-κB is an important transcription factor for pro-
inﬂammatory cytokines production. Because HMGB1 promotes
PRRSV-induced NF-κB promoter activation, it should enhance
PRRSV-induced inﬂammatory cytokine expression. To test this
hypothesis, PRRSV-infected MARC-145 cells were transfected with
HMGB1-speciﬁc siRNAs or treated with puriﬁed HMGB1 protein.
Cells were collected at 36 hpi for detecting cytokine message
expression by real-time RT-PCR. Consistent with previous reports
(Bi et al., 2014; Flores-Mendoza et al., 2008; Han et al., 2014; Luo et
al., 2011a; Mateu and Diaz, 2008; Wang et al., 2011; Zhang et al.,
2013a), PRRSV infection was able to induce IL-6, IL-8, RANTES and
TNF-α expression in MARC-145 cells. However, knockdown of
HMGB1 signiﬁcantly reduced the production of IL-6, IL-8, RANTES
and TNF-α (Fig. 4A). As expected, treatment with the recombinant
HMGB1 resulted in an increase in IL-6, IL-8, RANTES and TNF-α
mRNA expression levels (Fig. 4B). We also assessed the effects of
HMGB1 on PRRSV-induced cytokine expression in PAMs and
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similar results could be obtained (Fig. 4C and D), further demon-
strating that HMGB1 promotes expression of inﬂammatory cyto-
kines during PRRSV infection.
TLR2, TLR4 and RAGE are involved in PRRSV-induced NF-κB activation
and expression of inﬂammatory cytokines
TLR2, TLR4, TLR9 and RAGE are the known receptors for HMGB1-
mediated NF-κB activation and subsequent inﬂammatory cytokine
production (He et al., 2012; Hirata et al., 2013; Park et al., 2006). To
dissect the signal pathways involved in HMGB1-promoted inﬂamma-
tory effect during PRRSV infection, speciﬁc siRNA targeting RAGE,
TLR2, TLR3, TLR4 and TLR9 were synthesized. The siRNA targeting
TLR3 was included because TLR3 is not the receptor of HMGB1; thus,
we can use this siRNA as an additional control in subsequent
experiments. Transfection of MARC-145 cells with speciﬁc siRNAs
signiﬁcantly reduced the endogenous expression of corresponding
target receptors compared with that by negative control siRNAs (data
Fig. 1. Release of HMGB1 protein by PRRSV-infected cells. MARC-145 cells (A) and PAMs (D) are either mock-infected or infected with PRRSV at a multiplicity of infection
(MOI) of 0.1. Cells are ﬁxed and incubated with antibodies against the PRRSV N protein (red) and HMGB1 (green). The nuclei of cells are stained with DAPI (blue). The scale
bar indicates 5 μm. MARC-145 cells (B) and PAMs (E) are mock-infected or infected with PRRSV at an MOI of 0.1. Culture supernatants are collected at the indicated time
points and subjected to ELISA to analyze HMGB1 release. MARC-145 cells (C) and PAMs (F) are infected with PRRSV at different MOIs (0.001, 0.01, 0.1, 1.0 MOI in Marc-145
cells; 0.01, 0.1, 1.0 MOI in PAMs) or UV-inactivated PRRSV. Culture supernatants are collected to determine levels of HMGB1 protein using ELISA. The values shown in (B–F)
represent the mean7SD from three independent experiments performed in triplicate. *Po0.05 and **Po0.01 compared with mock-infected cells.
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not shown). The siRNAs targeting RAGE or TLRs (TLR2, 3, 4, and 9)
were co-transfected with pNF-κB-Luc and pRL-TK in MARC-145 cells
before PRRSV infection. As shown in Fig. 5A, speciﬁc siRNAs targeting
RAGE, TLR2 and TLR4 signiﬁcantly inhibit NF-κB transcriptional
activity, however this is not the case for TLR9. As expected, no
inﬂuence could be observed in cells transfected with TLR3-speciﬁc
siRNAs. Further studies showed that speciﬁc siRNAs targeting RAGE,
TLR2 and TLR4 also inhibited IL-6, IL-8, RANTES and TNF-α mRNA
expression in PRRSV-infected MARC-145 cells (Fig. 5B). Collectively,
these ﬁndings suggested that HMGB1 may act as a mediator for NF-κB
activation and inﬂammatory cytokine production through RAGE, TLR2
and TLR4 receptors in PRRSV-infected MARC-145 cells.
Discussion
Although HMGB1 has recently been proposed as the most
signiﬁcant immune modulator during the porcine response to
PRRSV infection, there is no experimental evidence to conﬁrm this,
only a meta-analysis (Badaoui et al., 2013). In our present study,
we found that PRRSV infection triggers the translocation and
secretion of HMGB1 in MARC-145 cells and PAMs. The released
HMGB1 mediates PRRSV-induced NF-κB activation and subsequent
inﬂammatory responses and may have no effect on PRRSV replica-
tion. HMGB1 appears to function as a pro-inﬂammatory mediator
through TLR2, TLR4 and RAGE receptors during PRRSV infection.
HMGB1 is a non-histone chromosomal nuclear protein. Because
there is no signal sequence at its N-terminus, HMGB1 cannot be
released via the classical endoplasmic reticulum–Golgi secretory
pathway (Wang et al., 2006). However, exogenous stimulation,
including pathogen infection, can lead to cytoplasmic transloca-
tion of HMGB1 and its subsequent release into the extracellular
milieu. The cytoplasmic translocation and release of HMGB1 in
virus-infected cells have been reported previously following infec-
tion with West Nile virus, Dengue virus, HIV, hepatitis C virus
(HCV) and herpes simplex virus type 2 (Barqasho et al., 2010; Chen
et al., 2008; Chu and Ng, 2003; Gaillard et al., 2008; Jung et al.,
2011; Kamau et al., 2009). In our present study, we found that
following infection with PRRSV, the cytoplasmic translocation and
release of HMGB1 were observed in MARC-145 cells and PAMs. It
should be noted that secreted HMGB1 was only detected at 24 hpi
and later in MARC-145 cells, and at 12 hpi and later in PAMs.
Previous studies have revealed that HMGB1 shuttles from the
nucleus to the cytosol, where it accumulates in intracellular
vesicles prior to secretion. This process can take up to 8 h to
complete (Andersson and Tracey, 2011; Gardella et al., 2002; Wang
et al., 1999), suggesting that HMGB1 is a late cytokine. Although
the molecular mechanisms regarding the translocation and release
of HMGB1 are not fully understood, previous work has shown that
HMGB1 proteins are translocated from the nucleus to the cyto-
plasm, or even secreted into the extracellular milieu under condi-
tions in which intracellular reactive oxygen species (ROS) levels
are elevated (Tang et al., 2010). It has been demonstrated that
PRRSV infection signiﬁcantly increases ROS production (Lee and
Kleiboeker, 2007). Thus, the involvement of ROS is a likely
mechanism for PRRSV-induced HMGB1 release.
The role of HMGB1 in the extracellular milieu has been
intensively investigated during the last decade. To date, studies
addressing the question of whether HMGB1 exerts salutary or
detrimental effects on viral replication have generated conﬂicting
results (Troseid et al., 2011). Some studies showed that HMGB1
increases HIV-1 replication and persistence (Saidi et al., 2008;
Thierry et al., 2007), whereas other studies have reported that
extracellular HMGB1 inhibits HIV-1 replication (Cassetta et al.,
2009; Naghavi et al., 2003). In addition, HCV infection induces
HMGB1 translocation from the nucleus to the cytoplasm and
Fig. 2. HMGB1 does not affect PRRSV proliferation. (A) MARC-145 cells are
transfected with 50 nM/well of HMGB1 siRNAs or negative control (NC) for 48 h,
and then HMGB1 expression is determined by real-time RT-PCR and western
blotting. HMGB1 mRNA level is ﬁrst normalized to that of β-actin in the same
sample and then compared with that of cells transfected with NC. (**Po0.01).
(B) MARC-145 cells are transfected with siRNAs targeting HMGB1 for 24 h, and then
infected with PRRSV (MOI¼0.1). Plaque assays are conducted at 12, 24, 36 and
48 hpi. (C) MARC-145 cells are treated as in (B). At 12, 24, 36 and 48 hpi, cells are
collected for western blotting analysis using a speciﬁc antibody against the PRRSV
Nsp2 protein, with β-actin used as a loading control. (D, E) MARC-145 cells are
pretreated with either control IgG or an antibody against HMGB1 at the indicated
concentrations for 12 h. This is followed by infection with PRRSV (MOI¼0.1).
Infected cells are cultured in the presence of a HMGB1 antibody and collected at
different time points for plaque assay (D) and western blot analysis (E). (F, G)
MARC-145 cells are pretreated with either control GFP or puriﬁed HMGB1 protein
at the indicated concentrations for 12 h, followed by PRRSV infection (MOI¼0.1).
Infected cells are cultured in the presence of HMGB1 and collected at different time
points for plaque assay (F) and western blot analysis (G). All plaque results are the
mean7SD from three independent experiments performed in triplicate.
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secreted HMGB1 from infected cells can block the infection of
neighboring cells by HCV (Jung et al., 2011); however HMGB1
promotes inﬂuenza virus growth by enhancing viral polymerase
activity (Moisy et al., 2012). In our current study, we used three
different techniques to investigate the role of HMGB1 in PRRSV
replication: knockdown of endogenous HMGB1 with speciﬁc
siRNAs; blocking extracellular HMGB1 with an HMGB1 neutraliz-
ing antibody; and the extracellular addition of puriﬁed recombi-
nant HMGB1 protein. Results from the three approaches clearly
showed that HMGB1 did not signiﬁcantly affect PRRSV prolifera-
tion under our experimental conditions. Previous studies revealed
that HMGB1 can bind to the inﬂuenza virus nucleoprotein and
promote viral replication (Moisy et al., 2012). We attempted to
explore the possible interactions between HMGB1 and PRRSV-
encoded proteins using a yeast two-hybrid screen; however no
interactions were observed (data not shown).
Although HMGB1 is not associated with PRRSV replication, it
enhances PRRSV-induced NF-κB activation and subsequent expression
of inﬂammatory cytokines. PRRSV infection induces excessive produc-
tion of inﬂammatory cytokines in vivo, which could be associated with
PRRSV pathogenesis (Mateu and Diaz, 2008; Zhang et al., 2013b).
HMGB1 is a well-known DAMP molecule and its accumulation can
amplify cytokine cascades, stimulate inﬂammation, and mediate an
adverse inﬂammatory response (Bae, 2012; Czura et al., 2001; Kudo et
al., 2013). In our study, knockdown of HMGB1 inhibited PRRSV-
induced NF-κB promoter activity, phosphorylation levels of p65, and
expression of inﬂammatory cytokines. In contrast, addition of recom-
binant HMGB1 enhanced these effects, suggesting that it played an
important role in enhancing NF-κB activation and expression of
inﬂammatory cytokines.
RAGE, TLR2, TLR4 and TLR9 are known to be HMGB1 receptors
(Park et al., 2006; Tian et al., 2007), with the RAGE, TLR2 and TLR4
signaling pathways implicated in the production of various inﬂam-
matory molecules through activation of NF-κB following tissue
damage and injuries associated with burns (He et al., 2012;
Palumbo et al., 2007; Park et al., 2006, 2004). In our work, knock-
down of RAGE, TLR2, and TLR4 inhibited PRRSV-induced NF-κB
activation and expression of inﬂammatory cytokines, indicating that
RAGE, TLR2 and TLR4 receptors were involved in these processes.
Previous studies have demonstrated that HMGB1 is an essential
molecule of DNA-containing immune complexes that stimulates
production of cytokines through a TLR9-MyD88 pathway (Ivanov et
al., 2007; Tian et al., 2007). TLR9 is a sensor for CpG-DNA, not for RNA
virus, possibly explaining why knockdown of TLR9 has no effect on
the PRRSV-induced inﬂammatory response.
Although extracellular HMGB1 could act as a pro-inﬂammatory
cytokine, we found that treatment with puriﬁed recombinant
HMGB1 protein alone had no pro-inﬂammatory activity in
MARC-145 cells and PAMs (data not shown); however, PRRSV
infection coming with recombinant HMGB1 signiﬁcantly poten-
tiated NF-κB activation and IL-1β, IL-6, IL-8, RANTES, TNF-α
production. Similar observations were reported in other studies
Fig. 3. HMGB1 enhances NF-κB activation during PRRSV infection. (A) MARC-145 cells are co-transfected with HMGB1 siRNA, pNF-κB-Luc and pRL-TK for 24 h, followed by
PRRSV infection (MOI¼0.1). At 36 hpi cells are lysed and analyzed using a NF-κB luciferase reporter system. Values are presented as the mean7SD from three independent
experiments performed in triplicate. (*Po0.05 and **Po0.01). (B) MARC-145 cells are transfected with HMGB1 siRNA or NC for 24 h, and then cells are infected with or
without PRRSV (MOI¼0.1). At 36 hpi, phosphorylated p65 protein levels are analyzed western blotting with β-actin used as a loading control. HMGB1 protein level is also
analyzed by Western blot to detect silencing effect. (C) MARC-145 cells are co-transfected with pNF-κB-Luc and pRL-TK and then infected with PRRSV (MOI¼0.1). At 30 hpi,
infected cells are treated with puriﬁed HMGB1 (0.2 μg/ml) or control GFP for 6 h. Cells are lysed and analyzed with a NF-κB luciferase reporter system. Values are presented
as the mean7SD from three independent experiments performed in triplicate. (*Po0.05 and **Po0.01). (D) MARC-145 cells are mock-infected or infected with PRRSV
(MOI¼0.1). At 30 hpi, infected cells are treated with puriﬁed HMGB1 (0.2 μg/ml) or control GFP for 6 h. Cells are collected for western blotting analysis using an antibody
speciﬁc for p65, with β-actin used as a loading control. HMGB1 protein level is detected by Western blot with HMGB1-speciﬁc antibody.
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indicating that puriﬁed recombinant HMGB1 has no pro-inﬂam-
matory activity and only acts as a chemoattractant and a mitogen
(Bianchi, 2009; Dong et al., 2013). Indeed, extracellular HMGB1
can function by itself and/or forms inﬂammatory complexes with
other molecules, including LPS, IL-1 and nucleosomes (Bianchi,
2009; Cassetta et al., 2009; Chen et al., 2009; He et al., 2013;
Hreggvidsdottir et al., 2009; Qin et al., 2009; Tian et al., 2007).
Thus, we speculate that HMGB1 itself does not perform pro-
inﬂammatory activity, but may interact with other cytokines
induced by PRRSV, and then interacts with TLR2, TLR4 and RAGE
receptors to promote pro-inﬂammatory production.
In conclusion, our ﬁndings demonstrated that PRRSV infection
appears to trigger the translocation and secretion of HMGB1, which in
turn function through TLR2, TLR4 and RAGE receptors to mediate
NF-κB activation and subsequent production of inﬂammatory cyto-
kines. Our results provide new insight into understanding how PRRSV
infections induce excessive inﬂammatory responses. Further investiga-
tions into the role of HMGB1 in PRRSV pathogenesis will hopefully
provide potential therapeutic targets against PRRSV.
Materials and methods
Cells, virus and reagents
MARC-145 cells, a monkey kidney cell line highly permis-
sive for PRRSV infection, were cultured in Dulbecco's modiﬁed
Eagle's medium (DMEM, Invitrogen) supplemented with 10%
Fig. 4. HMGB1 mediates PRRSV-induced expression of cytokines. MARC-145 cells (A) and PAMs (C) are transfected with HMGB1-speciﬁc siRNAs or NC for 24 h, and then cells
are infected with or without PRRSV (MOI¼0.1). Cells are collected at 36 hpi for analysis of cytokine mRNA levels using real-time RT-PCR assays. MARC-145 cells (B) and PAMs
(D) are infected with or without PRRSV (MOI¼0.1). At 30 hpi, infected cells are treated with puriﬁed HMGB1 (0.2 μg/ml) or control GFP for 6 h. Cells are harvested for real-
time RT-PCR determination of cytokine mRNA levels. Values for real-time RT-PCR results are presented as the mean7SD from three independent experiments performed in
triplicate. (*Po0.05 and **Po0.01).
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heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin and
100 μg/ml streptomycin in a humidiﬁed incubator with 37 1C/5%
CO2. Porcine alveolar macrophages (PAMs) were isolated from a
5-week-old PRRSV-negative herd by bronchoalveolar lavage after
necropsy. The isolated PAMs were also detected for common swine
pathogens, including pseudorabies virus (PRV), porcine circovirus
type 2 (PCV-2), swine inﬂuenza virus, porcine parvovirus (PPV),
and Japanese encephalitis virus (JEV), by RT-PCR. Only RT-PCR
negative PAMs were used for our study. Isolated PAMs were
maintained in RPMI-1640 medium (Invitrogen) with 10% heated-
inactivated FBS, an antibiotic–antifungal mix (100 U/ml penicillin,
100 mg/ml streptomycin; Invitrogen) at 37 1C/5% CO2. PRRSV strain
WUH3 (GenBank Accession No. HM853673), isolated from the
brains of pigs suffering from “high fever” syndrome in China at the
end of 2006, and identiﬁed as a highly pathogenic PRRSV (HP-
PRRSV), was used throughout our study (Li et al., 2009). The anti-
HMGB1 neutralizing antibody and isotype control IgG were
purchased from Biolegend (Canada). Antibodies against NF-κB
p65 and phosphor-NF-κB p65 were purchased from Cell Signaling
Technology (USA). Secondary antibodies for immunostaining were
purchased from Invitrogen and Sigma-Aldrich. The puriﬁed
recombinant HMGB1 protein and control protein GFP were pur-
chased from Abcam (Hong Kong).
Plasmids, siRNA and cell transfection
The luciferase reporter plasmid pNF-κB-Luc was purchased from
Stratagene. We purchased small interfering RNAs (siRNAs) target-
ing HMGB1, TLR2, TLR3, TLR4, TLR9, and RAGE from GenePharma
(Shanghai, China), and the sequences are listed in Table 1. Plasmids
and siRNAs were transfected into cells using Lipofectamine 2000
(Invitrogen) according to the manufacturer's protocol.
Detection of cytokines using real-time RT-PCR
MARC-145 cells or PAMs in 24-well plates were transfected
with speciﬁc siRNAs (50 nM/well) and then infected with PRRSV at
a multiplicity of infection (MOI) of 0.1. At 36 h post-infection (hpi),
total RNA was extracted from cells using TRIzol reagent (Invitro-
gen) according to the manufacturer's instructions. In alternative
experiments, MARC-145 cells or PAMs were infected with PRRSV
(MOI¼0.1); at 30 hpi cells were treated with recombinant HMGB1
or control GFP. Total RNA was extracted from cells at 36 hpi. Once
RNA was extracted, we reverse transcribed 1 μg of each sample
into cDNA using a Transcriptor First Strand cDNA Synthesis Kit
(Roche). We then used 1 mL of the resulting cDNA in SYBR green
qPCR assays. The abundance of individual mRNA transcripts in
Fig. 5. HMGB1 receptors are involved in PRRSV-induced NF-κB activation and expression of inﬂammatory cytokines. (A) We co-transfected siRNAs targeting RAGE or TLRs
(TLR2, 3, 4, 9) with pNF-κB-Luc and pRL-TK into MARC-145 cells. At 24 h post-transfection, cells are then infected with PRRSV (MOI¼0.1). At 36 hpi, cells are lysed and
analyzed using an NF-κB luciferase reporter system. Values are presented as the mean7SD from three independent experiments performed in triplicate. (*Po0.05 and
**Po0.01). (B) MARC-145 cells are transfected with speciﬁc siRNAs targeting RAGE or TLRs (TLR2, 3, 4, 9) for 24 h, and then infected with PRRSV (MOI¼0.1). At 36 hpi,
cytokine mRNA levels are analyzed by real-time RT-PCR. Values are presented as the mean7SD from three independent experiments performed in triplicate. **Po0.01 (for
positive PRRSV group compared to negative control); ♯Po0.05; ♯♯Po0.01 (for positive PRRSV compared to speciﬁc siRNAs group).
Table 1
The sequences of siRNAs used in this study.
Gene name siRNA sequence (sense 50–30) siRNA sequence (anti-sense 50–30)
HMGB1-MARC CUGCUAAGCUGAAGGAGAATT' UUCUCCUUCAGCUUAGCAGTT
HMGB1-PAM CTGCTAAGCTGAAGGAGAATT TTCTCCTTCAGCTTAGCAGTT
RAGE GCCGGAAAUUAUAGAUUCUTT AGAAUCUAUAAUUUCCGGCTT
TLR2 CGGAGAGACUUUGCUUACUTT AGUAAGCAAAGUCUCUCCGTT
TLR3 CAACUUUCUUGGGACUAAATT UUUAGUCCCAAGAAAGUUGTT
TLR4 GUGCAGGCAUAAUCUUCAUTT AUGAAGAUUAUGCCUGCACTT
TLR9 GCCUCAACCUCAAGUGGAATT UUCCACUUGAGGUUGAGGCTT'
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each sample was assayed three times. Gene expression was
measured as described previously (Wang et al., 2012). Primer
sequences are listed in Table S1.
Luciferase reporter assays
MARC-145 cells cultured in 24-well plates were co-transfected
with 100 ng/well of pNF-κB-Luc, 50 ng/well of pRL-TK (as an
internal control to normalize the transfection efﬁciency, Promega),
and speciﬁc siRNA or negative control (50 nM/well), followed by
PRRSV infection (MOI¼0.1). In alternative experiments, sub-
conﬂuent MARC-145 cells were co-transfected with pNF-κB-Luc
(100 ng/well) and pRL-TK (50 ng/well) prior to PRRSV infection
(MOI¼0.1); cells were then treated with recombinant HMGB1 or
control GFP at 30 hpi. At 36 hpi, cells were lysed to determine
ﬁreﬂy luciferase and Renilla luciferase activities using a Dual-
luciferase reporter assay system (Promega) as per the manufac-
turer's suggestions. We have presented our results as relative
ﬁreﬂy luciferase activity normalized to Renilla luciferase activity
from three independent experiments.
Western blot analysis
Brieﬂy, MARC-145 cells cultured in 60-mm dishes were transfected
with HMGB1-speciﬁc siRNA prior to PRRSV infection (MOI¼0.1) or
treated with puriﬁed HMGB1 protein at 30 h after PRRSV infection. At
36 hpi, the cells were harvested by adding lysis buffer, and protein
concentrations were measured in whole cellular extracts. Equal
amounts of samples were then subjected to SDS-PAGE and analyzed
for expression of PRRSV nonstructural protein 2 (Nsp2) (Wang et al.,
2013), HMGB1, p65 or p-p65 protein by western blotting using speciﬁc
antibodies, respectively. Expression of β-actin was detected with an
anti-β-actin mouse monoclonal antibody (MAb) (Beyotime, China) to
demonstrate equal protein sample loading.
PRRSV titration
Plaque assays were conducted as described previously (Luo et
al., 2011b). Brieﬂy, MARC-145 cultures that were 95% conﬂuent in
6-well culture plates were infected for 1 h with 10-fold serial
dilutions (1 mL) of PRRSV-containing samples. After three washes
with phosphate-buffered saline (PBS; pH 7.4), cells were overlaid
with 1.8% (w/v) Bacto agar mixed with 2XDMEM at a 1:1 ratio
supplemented with 0.05 mg/mL neutral red. Plaques were counted
at 4 dpi, and average plaque number and standard deviations were
calculated from three independent experiments. We expressed
virus titer as plaque-forming units (PFU)/mL.
Indirect immunoﬂuorescence assays
To examine the subcellular localization of HMGB1, MARC-145
cells or PAMs were infected with PRRSV (MOI¼0.1). At 30 hpi, cells
were ﬁxed with 4% paraformaldehyde for 20 min at room tem-
perature before permeabilization with 0.1% Triton X-100. Cells
were then incubated with a mouse monoclonal antibody against
the PRRSV N protein (SDOW17; Rural Technologies, USA) and a
rabbit antibody against HMGB1 (Novus Biologicals, USA). Follow-
ing incubation with the primary antibodies, cells were incubated
with Alexa Flour 488-conjugated anti-rabbit and Alexa Fluor 555-
conjugated anti-mouse antibodies (Invitrogen). Cells were coun-
terstained with 1 mg/mL 40,60-diamidino-2-phenylindole (DAPI;
Beyotime) for 15 min and visualized using an LSM 510 Meta
confocal laser-scanning microscope (Carl Zeiss, Germany).
Measurement of secreted HMGB1 protein
Secreted HMGB1 in cell supernatants was quantiﬁed using a
commercial sandwich enzyme-linked immunosorbent assay
(ELISA) kit according to the manufacturer's protocol (USCN, China).
Statistical analysis
Data are presented as the mean7SD for at least three inde-
pendent experiments. Student's t-test was used to analyze differ-
ences between two experimental groups. A P-value less than 0.05
was considered signiﬁcant and a P-value less than 0.01 was
considered highly signiﬁcant.
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